Authors: RAFAEL E DURAJ F RUDSTROM H WILCZEK H ERICZON B

Citation: E. Rafael et al., EFFECT OF URSODEOXYCHOLIC ACID TREATMENT FOR CHOLESTASIS IN LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(6), 1995, pp. 3501-3502

Authors: HAGGLUND H RINGDEN O LJUNGMAN P WINIARSKI J ERICZON B TYDEN G

Citation: H. Hagglund et al., NO BENEFICIAL-EFFECTS, BUT SEVERE SIDE-EFFECTS CAUSED BY RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR FOR TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Transplantation proceedings, 27(6), 1995, pp. 3535-3535

Authors: NEUHAUS P PICHLMAYR R WILLIAMS R BECHSTEIN WO BLUMHARDT G MCMASTER P MAYER D BUCKELS J CALNE R FRIEND P JOUGHIN C WINKLER M RINGE B OTTO G BLEYL J DEVLIN J OGRADY J GROTH C ERICZON B DURAJ F BISMUTH H SAMUEL D RUCAY P

Citation: P. Neuhaus et al., RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN PREVENTION OF LIVER ALLOGRAFT-REJECTION, Lancet, 344(8920), 1994, pp. 423-428